跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,397 条关于
“ADX-626”
全部
5,397
临床试验
3,426
药物
1,222
机构
27
资讯
722
昨天
ADARx Raises $446M in Upsized Nasdaq IPO, Adds AbbVie Investment for siRNA Pipeline
去年
Q32 Bio Delays Phase 2 Trial of ADX-097 in ANCA-Associated Vasculitis
11个月前
ADARx Pharmaceuticals Initiates Phase 3 Trial for ADX-324 in Hereditary Angioedema, Receives FDA Orphan Drug Designation
11个月前
ADARx Pharmaceuticals to Present Phase 1 Data for ADX-038 siRNA Therapy at ASN Kidney Week 2025
去年
Q32 Bio Announces Q3 2024 Results and Highlights Clinical Progress of Bempikibart and ADX-097
3年前
Aldeyra Therapeutics Advances Novel Therapies for Ocular and Systemic Immune-Mediated Diseases
11个月前
Aldeyra Therapeutics Pivots to Next-Generation RASP Modulators Despite Phase II Success
去年
Q32 Bio's Bempikibart Fails Primary Endpoint in Atopic Dermatitis Trial, Alopecia Data Marred by Protocol Issues
去年
FDA Accepts Aldeyra's Reproxalap NDA for Dry Eye Disease Treatment
9个月前
FDA Extends Review Timeline for Aldeyra's Reproxalap Dry Eye Treatment to March 2026
第 1 页,共 73 页
上一页
下一页